HUTCHMED (China) Limited (AIM:HCM)
London
· Delayed Price · Currency is GBP · Price in GBX 234.00
-0.50 (-0.21%)
Aug 14, 2025, 4:35 PM GMT+1
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| Oncology/Immunology - Research and Development | 2.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology/Immunology - Research and Development Growth | 829.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Ventures | 2.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Ventures Growth | 17.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology/Immunology - Marketed Products | 1.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology/Immunology - Marketed Products Growth | 31.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commercial Platform - Prescription Drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commercial Platform - Prescription Drugs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commercial Platform - Consumer Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commercial Platform - Consumer Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovation Platform - Drug Research & Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovation Platform - Drug Research & Development Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| China | 3.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 13.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States and Others | 2.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|